Ignite Creation Date:
2024-07-17 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06479759
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-06-24
Brief Title:
LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Organization:
Shanghai Pulmonary Hospital Shanghai China
Organization Data
Organization:
Shanghai Pulmonary Hospital Shanghai China
Class:
OTHER
Study ID:
2023LY0834
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Lead Sponsor Class:
OTHER
Responsible Party:
Chunxia Su
Responsible Party Title:
Director of clinical research center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Pulmonary Hospital Shanghai China
Old Name:
None
Old Organization:
None